Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro cytogenicity / chromosome aberration study in mammalian cells
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
experimental study
Adequacy of study:
key study
Study period:
20 Dec 1989 - 06 Aug 1990
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: see 'Remark'
Remarks:
Acceptable, well-documented study which meets basic scientific principles, with acceptable restrictions. The study was performed on an analogue substance (for justification of read-across, please refer to the corresponding assessment report in Section 13).

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1990
Report date:
1990

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
Deviations:
yes
Remarks:
lack of study details, purity of test substance not specified
GLP compliance:
yes
Type of assay:
in vitro mammalian chromosome aberration test

Test material

Constituent 1
Reference substance name:
Sodium N-(2-carboxyethyl)-N-dodecyl-β-alaninate
EC Number:
239-032-7
EC Name:
Sodium N-(2-carboxyethyl)-N-dodecyl-β-alaninate
Cas Number:
14960-06-6
IUPAC Name:
Sodium Lauriminodipropionate
Test material form:
other: liquid
Details on test material:
- Common name : Sodium lauriminodipropionate
- For more details, see below the Confidential details for test material
Specific details on test material used for the study:
The study was performed on a commercial product (aqueous solution) as the test item is manufactured and used in a liquid form.

Method

Target gene:
not applicable
Species / strain
Species / strain / cell type:
Chinese hamster Ovary (CHO)
Metabolic activation:
with and without
Metabolic activation system:
cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with Aroclor 1254
Test concentrations with justification for top dose:
With S9:
. 8 hours harvest - 0.21, 0.28, 2.38 µl/mL
. 12 hour harvest - 0.28, 0.38, 0.50 µl/mL

Without S9:
. 8 hour harvest - 0.48, 0.63, 0.84 µl/mL
. 12 hour harvest - 0.63, 0.84, 1.13 µl/mL
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: water
Controls
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: Triethylenemelamine (TEM, 0.25 µg/mL, -S9); Cyclophosphamide (CP, 20 µg/mL, +S9)
Details on test system and experimental conditions:
METHOD OF APPLICATION: in medium

DURATION
- Exposure duration: 8 and 12 hours

NUMBER OF REPLICATIONS: 2

NUMBER OF CELLS EVALUATED: 100 per culture

DETERMINATION OF CYTOTOXICITY
- Method: mitotic index
Statistics:
The cytotoxic effects of treatment are expressed relative to the solvent control (relative cloning efficiency). The number and types of aberrations found are presented for each treatment flask. Duplicate treatment flasks were compared using the Fisher's exact test and, if not statistically significant, combined for treatment comparison. The percentage of damaged cells (numerical and structural) in the total population of cells examined was calculated for each group. A statistical analysis of the percent aberrant cells per dose was made using the Fisher's exact test. The average number of aberrations per cell was reported but no statistical analysis was applied. The Cochran-Armitage trend test was performed between the solvent and treatment groups for each treatment condition and harvest time to test for evidence of a dose response.

Results and discussion

Test results
Species / strain:
Chinese hamster Ovary (CHO)
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
Relative cloning efficiency at the highest dose level tested of 34% and 1% in the 8 hour and 12 hour non-activated studies, respectively, and 70% and 38% in the 8 hour and 12 hour S9 activated studies, respectively.
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: stock concentrations were adjusted to pH7 in order to ensure neutrality of the treatment medium
- Effects of osmolality: osmolality was measured before the main experiments and concentrations chosen where no difference in osmolality was observed

RANGE-FINDING/SCREENING STUDIES:
Dose levels were chosen according to a range-finding toxicity study which was based on cloning efficiency relative to the solvent control. Based upon the findings of the toxicity study dose levels 0.5 and 1.5 µl/mL were the high doses selected for further study in the non-activated and S9 activated studies, respectively.
The average cell generation time (AGT) was calculated in the non-activated and S9 activated studies for the solvent and the two highest test concentrations yielding metaphase cells. At the absence of cell cycle delay harvest times were set at 8 and 12 hours after initiation of treatment for non-activated and S9 activated studies.
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Any other information on results incl. tables

Table 1: summary of cytogenetic assay results

 Treatment1 Harvest time (hour)  Mean mitotic index2  Cells scored  Cels with structural aberrations (%)3,4  Structural aberrations per cell (mean ± SD)5
Non-activated study
untreated cells   8  3.4  100  0  0 .000 ± 0.000
 water  8  4.1  100  1  0.010 ± 0.100
 0.21 µL/mL  8  3.9  100  0  0.000 ± 0.000
 0.28 µL/mL  8  2.2  100  1  0.010 ± 0.100
 0.38 µL/mL  8  0.2  67  0  0.000 ± 0.000
           
 untreated cells  12  4.2  100  0  0.000 ± 0.000
 water  12  3.5  100  0  0.000 ± 0.000
 0.28 µL/mL  12  2.5  100  1  0.010 ± 0.100
 0.38 µL/mL  12  0.8  100  2  0.020 ± 0.141
 0.50 µL/mL  12  0.2  64  1  0.016 ± 0.125
 TEM, 0,25 µg/mL  12  0.9  100  11  0.130 ± 0.393

S9 activated study

 untreated cells  8  2.5  100  1  0.010 ± 0.100
 water  8  2.3  100  3  0.030 ± 0.171
 0.48 µL/mL  8  1.9  100  1  0.010 ± 0.100
 0.63 µL/mL  8  2.1  100  1  0.010 ± 0.100
 0.84 µL/mL  8  0.8  100  1  0.010 ± 0.100
           
 untreated cells  12  3.7  100  1  0.010 ± 0.100
 water  12  3.3  100  1  0.010 ± 0.100
 0.63 µL/mL  12  3.7  100  3  0.030 ± 0.171
 0.84 µL/mL  12  4.1  100  2  0.020 ± 0.141
 1.13 µL/mL  12  0.9  55  0  0.000 ± 0.000
 CP, 20µg/mL  12  1.8  100  12  0.130 ± 0.367

1 CHO cells were treated at 37°C for 4 hours

2 Mitotic Index = cells in mitosis per 500 cells counted, expressed as a percentage

3 Structural aberrations include unanalyzable cells and cells with one ore more aberrations, excluding gaps

4 significantly increased above the control using Fisher's exact test; *p<0.025

5 Gaps and unanalyzable cells are not included; SD = standard deviation

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative

Under the conditions of the assay described in this report, sodium lauriminodipropionate did not induce a significant increase in chromosome aberration in the CHO cytogenicity study.
Executive summary:

Sodium lauriminodipropionate was tested in a chromosome aberration assay using Chinese hamster ovary cells. The assay was conducted both in the absence and presence of an Aroclor induced rat liver S9 activation system. Dose levels of 0.21, 0.28 and 0.38 µl/mL in the 8 hour non-activated study, 0.28, 0.38 and 0.5 µl/mL in the 12 hour non-activated study, 0.48, 0.63 and 0.84 µl/mL in the 8 hour S9-activated study and dose levels 0.63, 0.84 and 1.13 µl/mL in the 12 hour S9-activated study were selected as the highest, non-precipitating concentrations with or without S9 which could be evaluated for chromosome aberrations.

Survival (relative cloning efficiency) at the highest dose level scored was 34% and 1% in the 8 and 12 hour non-activated studies, respectively, and 70% and 38% in the 8 and 12 hour S9 activated studies, respectively.

The test article did not induce a significant increase in chromosome aberrations at either harvest time, 8 or 12 hours, in the absence of presence of S9 activaton. The test substance was concluded to be negative in the CHO cytogenicity study.